Skip to content
Screener

Hims & Hers Health HIMS Financing Cash Flow

Financing Cash Flow at other companies

WW International, Inc. logo
WW International, Inc.WW
$0+100%
LifeMD, Inc. logo
LifeMD, Inc.LFMD
-$696.04K+14.3%
Amazon logo
AmazonAMZN
$10.15B+500%
Teladoc Health logo
Teladoc HealthTDOC
-$2.45M-418%
Veradermics
 logo
Veradermics MANE
$269.11M+3,095%
PBH
Prestige Consumer HealthcarePBH
$1.02B+2,907%

Other financials

Income statement

See full
Revenue$608.1M+3.8%
Gross profit$396.8M-7.9%
Operating income-$78.3M-235%
Net income-$92.1M-286%
EPS (diluted)-$0.40-300%

Balance sheet

See full
Cash & equivalents$222.3M-19.2%
Total debt$157.9M+149%
Total equity$446.2M-18.8%
Total assets$2.3B+154%

Cash flow

See full
Operating cash flow$89.4M-18.1%
CapEx$8.8M-19.9%
Free cash flow$80.5M-17.9%

Valuation

See full
Market cap$7.44B-36.6%
Enterprise value$7.38B-30.9%
P/S3.1×-2.7×

Profitability

See full
Gross margin71.7%-5.3pp
Operating margin-1.3%-7.5pp
Net margin-0.6%-9.8pp
FCF margin11.9%-5.8pp

Returns & leverage

See full
Return on equity-2.7%-39.4pp
Debt / equity0.4×+0.2×
Current ratio1.7×+0.1×

Where this comes from

Reported directly by Hims & Hers Health in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The source filing: Hims & Hers Health’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001773751-26-000076
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Payments for taxes related to net share settlement of equity awards(39,206)(25,711)
Payments for acquisition-related earn-out consideration(43,682)
Payments for debt issuance costs(1,235)
Net cash used in financing activities(77,880)(23,018)
Foreign currency effect on cash and cash equivalents(2,380)243
(Decrease) increase in cash, cash equivalents, and restricted cash(6,350)53,519
Cash, cash equivalents, and restricted cash at beginning of period228,616221,440
Cash, cash equivalents, and restricted cash at end of period$222,266$274,959

Item 1. Financial Statements

FAQ

What is Hims & Hers Health's financing cash flow?
Hims & Hers Health (HIMS) reported financing cash flow of -$77.88M in Q1 2026.
How has Hims & Hers Health's financing cash flow changed year-over-year?
Hims & Hers Health's financing cash flow decreased by 238.3% year-over-year, from -$23.02M to -$77.88M.
What is the long-term trend for Hims & Hers Health's financing cash flow?
Over 2 years (2022 to 2024), Hims & Hers Health's financing cash flow has grown at a 79.5% compound annual growth rate (CAGR), from -$33.48M to -$107.85M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Ask your AI about Hims & Hers Health's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude